Business Description
Apotea AB (publ)
ISIN : SE0023313762
Total Employee Number:
726Compare
Compare
Traded in other countries / regions
APOTEA.SwedenV30.GermanyAPOTEs.UK IPO Date
2024-12-11Description
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 0.54 | |||||
Interest Coverage | 26.1 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 8.36 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.8 | |||||
3-Year EBITDA Growth Rate | 64.2 | |||||
3-Year EPS without NRI Growth Rate | 96.5 | |||||
3-Year Book Growth Rate | 37.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.18 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.03 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 86.48 | |||||
14-Day RSI | 80.66 | |||||
6-1 Month Momentum % | 12.03 | |||||
12-1 Month Momentum % | -42.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 0.58 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 48.97 | |||||
Days Sales Outstanding | 17.54 | |||||
Days Payable | 47.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.25 | |||||
Shareholder Yield % | 0.52 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 26.98 | |||||
Operating Margin % | 4.2 | |||||
Net Margin % | 3.24 | |||||
EBITDA Margin % | 6.85 | |||||
FCF Margin % | 2 | |||||
OCF Margin % | 3.08 | |||||
ROE % | 28.55 | |||||
ROA % | 11.51 | |||||
ROIC % | 19.29 | |||||
3-Year ROIIC % | 39.06 | |||||
ROC (Joel Greenblatt) % | 33.34 | |||||
ROCE % | 28.69 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 31.42 | |||||
PE Ratio without NRI | 31.42 | |||||
PS Ratio | 1.02 | |||||
PB Ratio | 8.15 | |||||
Price-to-Tangible-Book | 8.56 | |||||
Price-to-Free-Cash-Flow | 50.86 | |||||
Price-to-Operating-Cash-Flow | 33.01 | |||||
EV-to-EBIT | 24.34 | |||||
EV-to-EBITDA | 15.08 | |||||
EV-to-Revenue | 1.03 | |||||
EV-to-FCF | 52.1 | |||||
Price-to-Graham-Number | 3.46 | |||||
| Price-to-Net-Current-Asset-Value | 42.06 | |||||
Earnings Yield (Greenblatt) % | 4.11 | |||||
FCF Yield % | 1.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Apotea AB (publ) Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 7,586.7 | ||
| EPS (TTM) (kr) | 2.36 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 48.8 | ||
| 14-Day RSI | 80.66 | ||
| 14-Day ATR (kr) | 0.000651 | ||
| 20-Day SMA (kr) | 65.2 | ||
| 12-1 Month Momentum % | -42.59 | ||
| 52-Week Range (kr) | 57.35 - 113.57 | ||
| Shares Outstanding (Mil) | 104.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Apotea AB (publ) Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Apotea AB (publ) Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-04 | In 163 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 07:30 | In 73 days | ||
| Second quarter earnings results for 2026 | 2026-07-17 07:30 | 65.20 (+0.00%) | ||
| SEK 0.600000 Cash Dividend | 2026-05-27 | 65.20 (+0.00%) | ||
| General meeting for 2026 | 2026-05-26 10:00 | 65.20 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 65.20 (+0.00%) | ||
| Annual report for 2025 | 2026-04-17 | 65.20 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-04 | 62.83 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-06 | 113.57 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-07-18 | 88.93 (+0.00%) |
Show
Entries
Apotea AB (publ) Frequently Asked Questions
What is Apotea AB (publ)(CHIX:APOTEs)'s stock price today?
The current price of CHIX:APOTEs is kr65.20. The 52 week high of CHIX:APOTEs is kr113.57 and 52 week low is kr57.35.
When is next earnings date of Apotea AB (publ)(CHIX:APOTEs)?
The next earnings date of Apotea AB (publ)(CHIX:APOTEs) is 2026-11-05.
Does Apotea AB (publ)(CHIX:APOTEs) pay dividends? If so, how much?
Apotea AB (publ)(CHIX:APOTEs) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Apotea AB (publ)
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers